Cargando…
CTA095, a Novel Etk and Src Dual Inhibitor, Induces Apoptosis in Prostate Cancer Cells and Overcomes Resistance to Src Inhibitors
Etk is a non-receptor tyrosine kinase, which provides a strong survival signal in human prostate cancer cells. Src, another tyrosine kinase that cross-activates with Etk, has been shown to play an important role in prostate cancer metastasis. Herein, we discovered a new class of Etk inhibitors. With...
Autores principales: | Guo, Wenchang, Liu, Ruiwu, Bhardwaj, Gaurav, Ma, Ai-Hong, Changou, Chun, Yang, Joy C., Li, Yuanpei, Feng, Caihong, Luo, Yan, Mazloom, Anisha, Sanchez, Eduardo, Wang, Yan, Huang, Wenzhe, Patterson, Randen, Evans, Christopher P., Lam, Kit S., Kung, Hsing-Jien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3744530/ https://www.ncbi.nlm.nih.gov/pubmed/23967135 http://dx.doi.org/10.1371/journal.pone.0070910 |
Ejemplares similares
-
Targeting Btk/Etk of prostate cancer cells by a novel dual inhibitor
por: Guo, W, et al.
Publicado: (2014) -
The potential of Src inhibitors
por: Elias, Daniel, et al.
Publicado: (2015) -
Structural and functional characterization of the divergent Entamoeba Src using Src inhibitor-1
por: López-Contreras, Luilli, et al.
Publicado: (2017) -
Optimization of Aminoimidazole Derivatives as Src Family Kinase Inhibitors
por: Francini, Cinzia Maria, et al.
Publicado: (2018) -
Structure and Characterization of a Covalent Inhibitor of Src Kinase
por: Gurbani, Deepak, et al.
Publicado: (2020)